Sonata Jodele, Kejian Zhang, Christopher E. Dandoy, Kasiani C

Slides:

Advertisements

Similar presentations

Trend, Risk Factors and Outcome of Thrombotic Microangiopathy in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Multi-Institutional Review

Advertisements

Michael A. Pulsipher, Christina Peters, Ching-Hon Pui

Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,

How to Treat MDS without Stem Cell Transplantation

Kristen M. Coleman, RN, BSN, Stella M

Biology of Blood and Marrow Transplantation

Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation Javier.

Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma Taewoong Choi, Murali K. Kodali, Wen-Kai Weng

Vitamin A Deficiency Is Associated with Increased Risk of Acute Graft Versus Host Disease in Children Dana T. Lounder, MD, Sonata Jodele, MD, Pooja Khandelwal,

Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma Brian Hess, MD, Kathryn Trinkaus, Ph.D.,

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced Avichai.

Eculizumab Treatment Improves Survival in Patients with High-Risk Hematopoietic Stem Cell Transplant (HSCT)-Associated Thrombotic Microangiopathy (TMA)

Optimizing Data Collection for Long-Term Follow-Up after Hematopoietic Stem Cell Transplant Jaskiran Kaur, Madhu Ragupathi, Alysa Pleiner, Luda Kushner,

Gregory Wallace, DO, Sonata Jodele, MD, Kasiani C

A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation

Pharmacogenetic Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplants Ashley Teusink,

Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell.

Pulmonary Arterial Hypertension in Pediatric Patients with Hematopoietic Stem Cell Transplant–Associated Thrombotic Microangiopathy Sonata Jodele, Russel.

Let Them Eat! Comparing a Neutropenic Diet to a Food Safety Based Diet in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) Cynthia.

Jane Kempenich, Kelly Buck, John Hermanson, Jason Dehn, MPH

Early Soluble ST2 Elevation Predicts Future Left Ventricular Systolic Dysfunction after Stem Cell Transplant Christopher E. Dandoy, MD, MSc, Thomas D.

Pulmonary Hypertension Associated with Bronchiolitis Obliterans after Stem Cell Transplant Christopher E. Dandoy, MD, MSc, Abigail Pate, Mikako Warren,

Donor-Recipient ABO Compatibility Independently Influences Survival after Allogeneic HSCT: Outcomes of 281 Patients from a Single Centre Duncan Purtill,

Treatment of Severe Mucositis Pain with Oral Ketamine Mouthwash

Pulmonary Hypertension after Hematopoietic Stem Cell Transplantation

Christopher C. Dvorak, Rajni Agarwal, Gary V. Dahl, John J

A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model Justin N. Baker,

Pauline A. Daniels, DO, Stella M

Twenty Years of Unrelated Donor Bone Marrow Transplantation for Pediatric Acute Leukemia Facilitated by the National Marrow Donor Program Margaret L.

A Single Ultra High Dose of Vitamin D is Safe and Feasible in Early Peri-Transplant Period to Prevent Vitamin D Deficiency in Pediatric HSCT Recipients

Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation Ashley Teusink,

Gregory Wallace, Sonata Jodele, Jonathan Howell, Kasiani C

Follicular Lymphoma: Prognostic Factors, Conventional Therapies, and Hematopoietic Cell Transplantation Laurie H. Sehn, Timothy S. Fenske, Ginna G. Laport

Sleep: An Unrecognized Casualty of Stem Cell Transplant

Seth Joshua Rotz, Nathan Luebbering, Bradley P. Dixon, Christopher E

Impact of Extremely Long Driving Distance on Distress and Physical Function in Hematopoietic Cell Transplant Recipients Rahul Banerjee, Jean C. Yi, Navneet.

A Novel Strategy in Managing Post-Liver Transplant Acute Graft-Versus-Host-Disease: The New Era (T)Rojan Horse Zeyad Kanaan, MD, William Tse, MD, FACP

Alternate-Day Micafungin Antifungal Prophylaxis in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Pharmacokinetic Study Parinda.

Priscila Badia, Heidi Andersen, David Haslam, Adam S

Increased Vitamin D Binding Protein Levels Are Associated with Improved Overall Survival Following Bone Marrow Transplant in Children Nathan Luebbering,

Endothelial Injury, Neutrophil Extracellular Traps, and Complement Activation in Thrombotic Microangiopathy and GVHD Nicholas J. Gloude, Sonata Jodele,

Kasiani C. Myers, Stella M. Davies

Eltrombopag Treatment for Primary and Secondary Thrombocytopenia Post Allogeneic and Autologous Stem Cell Transplantation is Effective and Safe Shahram.

Hemophagocytic Lymphohistiocytosis (HLH) after Hematopoietic Stem Cell Transplant (HSCT) or an Impostor: A Word of Caution! Anant Vatsayan, MD, Linda.

Biology of Blood and Marrow Transplantation

Children after Allogeneic Hematopoietic Cell Transplantation Can Develop BK Virus Nephropathy: Pilot Data Using Urinary Polyomavirus-Haufen Testing Benjamin.

Infection Prevention - Visitors and the Best of Intentions

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant.

The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation? Melhem.

Early Results of Phase II Study Using OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HCT-TMA) Samer.

Haploidentical Bmt and Post Transplant Cyclophosphamide: First Peruvian Experience Alfredo Wong, Mariela Moreno, Mayra Castillo, Juan Navarro, Lourdes.

Histologic Features of Intestinal Thrombotic Microangiopathy in Patients with High Risk TMA after HSCT Javier El-Bietar, MD, Mikako Warren, MD, Christopher.

Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data Brent R. Logan, Mei-Jie Zhang,

Merve Postalcioglu, Haesook T. Kim, Faruk Obut, Benjamin C

ASBMT and CBMTG Release Choosing Wisely BMT Recommendations

Development of an Assessment Tool for Patient Evaluation Prior to Hematopoietic Stem Cell Transplantation (HSCT) Jaskiran Kaur, Madhu Ragupathi, Eric.

Gerard Socié, K. Scott Baker, Smita Bhatia

Impact of Pharmacogenetics and Therapeutic Drug Monitoring On Optimizing Voriconazole Dosing in Pediatric Patients Undergoing Hematopoietic Cell Transplantation

Redesigning Care to Lower Episode Costs in Bone Marrow Transplantation

Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond Stanley R. Riddell, Michael C. Jensen, Carl.

Blood and Marrow Transplant Handbook

Therapeutic Immunosuppression Concentrations on Day 0 and the Development of Acute Graft Versus Host Disease (GVHD) in Hematopoietic Stem Cell Transplantation.

Influence of Body Weight on Melphalan Dosing in Autologous Stem Cell Transplantation Kendall Shultes, Christopher Arp, Keith Stockerl-Goldstein, Kathryn.

Evaluation of a Data-Derived Algorithm for Preemptive Use of Plerixafor for Stem Cell Harvest in Patients Eligible for Autologous Stem Cell Transplant.

Mammen Chandy Biology of Blood and Marrow Transplantation

Heather A. Himburg, PhD, Liman Zhao, Jenny Kan, John P. Chute, M.D.

IL-8 Levels Early after Bone Marrow Transplant are Associated with Later Complications of Stem Cell Transplantation Nikhil Dole, Nathan Luebbering, Nicholas.

Cardiac Dysfunction after Stem Cell Transplantation: Can Peritransplant Cardiac Troponin-I Predict Future Issues? Seth Joshua Rotz, MD, Thomas D. Ryan,

In Memoriam: E. Donnall Thomas

Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory- Confirmed Bloodstream Infections after Stem Cell Transplantation Christopher.

Presentation transcript:

Donor Genotype and Susceptibility to Transplant-Associated Thrombotic Microangiopathy Sonata Jodele, Kejian Zhang, Christopher E. Dandoy, Kasiani C. Myers, Adam Lane, Stella M. Davies Biology of Blood and Marrow Transplantation Volume 23, Issue 3, Pages S234-S235 (March 2017) DOI: 10.1016/j.bbmt.2016.12.461 Copyright © 2016 Terms and Conditions

Figure 1 Complement gene variants identified in HSCT recipients and donors. (A) HSCT recipients with TMA (n = 34). (B) HSCT recipients without TMA (n = 43). (C) Donors of HSCT recipients with TMA (n = 25). (D) Donors of HSCT recipients without TMA (n = 32). Biology of Blood and Marrow Transplantation 2017 23, S234-S235DOI: (10.1016/j.bbmt.2016.12.461) Copyright © 2016 Terms and Conditions